From the Project CBD Archives:
Both milk thistle and cannabis convey therapeutic benefits that are mediated by the endocannabinoid system.
And did cannabidiol really kill four-and-a-half mice?
Cannabis use may protect against steatosis, the abnormal accumulation of lipids in the liver.
Excerpted from “The Essential Guide to CBD” by the Editors of Reader’s Digest and Project CBD.
Scientific Research on CBD & Cannabis for Liver Disease:
- Long-term THC use safe for liver
- The endocannabinoid system and liver diseases
- Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
- Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis
- Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats
- Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol
- Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice
- Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation
- Potential of CBD for the treatment of viral hepatitis